Donchev Deyan, Ivanov Ivan N, Stoikov Ivan, Sabtcheva Stefana, Kalchev Yordan, Murdjeva Marianna, Dobreva Elina, Hristova Rumyana
National Reference Laboratory for Control and Monitoring of Antimicrobial Resistance, Department of Microbiology, National Center of Infectious and Parasitic Diseases, 26 Yanko Sakazov Blvd., 1504 Sofia, Bulgaria.
Laboratory for Clinical Microbiology, National Oncology Center, 6 Plovdivsko pole Str., 1797 Sofia, Bulgaria.
Microorganisms. 2023 Feb 10;11(2):444. doi: 10.3390/microorganisms11020444.
The genotyping of the multidrug-resistant species complex is essential to identify outbreaks and to track their source and spread. The aim of this study was to improve and extend the typeability, availability, cost and time efficiency of an existing multi-locus VNTR analysis (MLVA). A modified scheme (MLVA8+) was adopted and validated for strain-level differentiation of the three species involved in human pathology. A diverse set of 465 clinical isolates from 22 hospitals and 3 outpatient laboratories in Bulgaria were studied, where 315 were carbapenem-resistant. The MLVA8+ typeability was significantly improved and the typing data were validated against 158 isolates which were previously typed by WGS. The MLVA8+ results were highly concordant with the classic 7-locus MLST and the novel MLST, but had greater congruency coefficients (adjusted Wallace). A major advantage was the differentiation of the hybrid cluster ST258 into its corresponding clades. Furthermore, the applicability of MLVA8+ was demonstrated by conducting a retrospective investigation of the intra-hospital spread of KPC-, NDM- and OXA-48-like producers. The MLVA8+ has improved utility and extended typing scope to and , while its cost and time-to-result were reduced.
对多重耐药菌复合体进行基因分型对于识别疫情暴发以及追踪其源头和传播至关重要。本研究的目的是改进并扩展现有多位点可变数目串联重复序列分析(MLVA)的分型能力、可用性、成本和时间效率。采用了一种改良方案(MLVA8+)并对其在涉及人类病理学的三种细菌的菌株水平鉴别方面进行了验证。对来自保加利亚22家医院和3个门诊实验室的465株不同临床分离株进行了研究,其中315株对碳青霉烯类耐药。MLVA8+的分型能力显著提高,分型数据通过与158株先前采用全基因组测序分型的分离株进行比对得到验证。MLVA8+的结果与经典的7位点多位点序列分型(MLST)和新型MLST高度一致,但具有更高的一致性系数(调整后的华莱士系数)。一个主要优势是将杂交簇ST258分化为其相应的进化枝。此外,通过对产KPC、NDM和OXA-48样酶菌株的医院内传播进行回顾性调查,证明了MLVA8+的适用性。MLVA8+提高了实用性,将分型范围扩展到了[具体两种细菌名称未给出],同时降低了成本和获得结果的时间。